Israel Englander Provention Bio, Inc. Transaction History

Millennium Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $4.44 Million - $16 Million	662,410 Added 156.49%	1,085,705 $26.2 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.91 Million - $4.47 Million	423,295 New	423,295 $4.47 Million
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $155,271 - $310,542	42,540 New	42,540 $170,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $1.86 Million - $4.3 Million	-546,202 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.59 - $7.39 $1.33 Million - $1.75 Million	-237,320 Reduced 30.29%	546,202 $3.07 Million
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $1.24 Million - $1.83 Million	219,834 Added 39.0%	783,522 $5.02 Million
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $1.53 Million - $2.51 Million	227,727 Added 67.78%	563,688 $4.75 Million
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $1.89 Million - $3.64 Million	187,153 Added 125.77%	335,961 $3.53 Million
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $88,566 - $142,277	-7,512 Reduced 4.81%	148,808 $2.52 Million
Q3 2020 Nov 16, 2020	SELL	$10.34 - $15.2 $4.81 Million - $7.06 Million	-464,750 Reduced 74.83%	156,320 $2.01 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $321,803 - $700,468	41,204 Added 7.11%	621,070 $8.76 Million
Q1 2020 May 14, 2020	BUY	$5.42 - $17.75 $2.94 Million - $9.63 Million	542,553 Added 1454.06%	579,866 $5.34 Million
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $93,375 - $238,236	15,989 Added 74.98%	37,313 $556,000
Q3 2019 Nov 14, 2019	BUY	$6.83 - $13.0 $145,642 - $277,212	21,324 New	21,324 $145,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.